Interferon beta-1a Completed Phase 2 Trials for Disseminated Sclerosis Basic Science

IndicationsStatusPurposePhase
CompletedBasic Science2
clinicaltrials.gov IdentifierTitleDrugs
NCT00912860Immunogenicity and Safety Study of Serum-Free Avonex